LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) -- PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, plans to announce its operating and financial results for the first quarter of its fiscal year ending March 31, 2026 (“Q1 Fiscal 2026”) and host an investor webcast to discuss the results on Wednesday, August 13, 2025.

Momentum builds as company expands wellness offerings beyond airports and earns industry recognition Momentum builds as company expands wellness offerings beyond airports and earns industry recognition

HIGH POINT, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes (T1D), today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application directed to compositions of matter of crystalline forms of salts and co-crystals of cadisegliatin. The patent term runs through 2041.

EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today reported Q2 2025 financial results, provided operational highlights and outlined expected upcoming milestones.

LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) -- LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment, and technology platform, plans to announce its operating and financial results for the first quarter of its fiscal year ending March 31, 2026 (“Q1 Fiscal 2026”) and host an investor webcast to discuss the results on Wednesday, August 13, 2025.

- Released positive topline data from the VIRAGE Phase 2b study of VCN-01 (zabilugene almadenorepvec); expanded data to be presented at the European Society for Medical Oncology (ESMO) 2025 Congress in October -

COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results on Thursday August 14, 2025, before opening of the Nasdaq CM.

RIDGELAND, Miss.--(BUSINESS WIRE)--Cal-Maine Foods, Inc. (NASDAQ: CALM (“Cal-Maine Foods” or the “Company”), today announced the appointment of Keira Lombardo as the Company's first-ever Chief Strategy Officer (CSO), effective today. The creation of this role underscores Cal-Maine Food's commitment to delivering long-term value through operational excellence, innovation, and deeper stakeholder engagement. As CSO, Lombardo will work with the senior leadership team to further accelerate and shape.

BONITA SPRINGS, Fla.--(BUSINESS WIRE)--Herc Holdings Inc. (NYSE: HRI), one of North America's leading equipment rental suppliers operating through Herc Rentals Inc. (“Herc Rentals” or “the Company”), released its 2025 Corporate Citizenship Report, highlighting the company's progress on its environmental, social and governance initiatives, with a primary focus on activities and achievements throughout 2024 and early 2025. “Our purpose in building brighter futures is closely tied to our commitmen.

ADDISON, Texas--(BUSINESS WIRE)--Concentra®, (NYSE: CON) the nation's leader in occupational medicine, today announced the opening of a new medical center in Union City, Georgia. The medical center, Concentra Union City, is conveniently located at 6851 Shannon Parkway, Suite 5, Union City, Georgia 30291. “Concentra Union City marks our continued expansion in the Atlanta area,” said Janet Cobb, MD, senior vice president of Concentra medical operations. “We look forward to serving Atlanta employe.

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, is pleased to announce the publication of clinical data evaluating the use of its proprietary Pressure-Enabled Drug DeliveryTM (PEDDTM) technology in thyroid parenchymal embolization, a new application for the treatment of patients with sympt.

PITTSBURGH--(BUSINESS WIRE)--PPG (NYSE:PPG) today announced the appointment of Joe Gette, 53, currently vice president, deputy general counsel and secretary, as senior vice president, general counsel and secretary, effective Jan. 1, 2026. He will also join the company's operating and executive committees, reporting to PPG chairman and CEO Tim Knavish. In this role, Gette will succeed Anne M. Foulkes, 62, current senior vice president and general counsel, who has announced her intent to retire.

AMC Entertainment surpassed Wall Street estimates for second-quarter revenue on Monday, as top U.S. blockbusters such as "A Minecraft Movie" and "Lilo & Stitch" drove more people to its theater chains.

Fundstrat market technician sees Tesla stock testing $368 if shares can close above $338 in the coming days.

PAAS, HAS and ADRNY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 11, 2025.

PITTSBURGH , Aug.11, 2025 /PRNewswire/ -- Koppers Holdings Inc. (NYSE: KOP) today announced that the company will host meetings with the investment community as follows: Boston on August 12, 2025 New York on August 13, 2025 Koppers management will be represented by Leroy Ball, Chief Executive Officer and Chairman of the Board, and Quynh McGuire, Vice President of Investor Relations. Presentation materials will be available on www.koppers.com in the Investor Relations section of the company's website.

Arizona's Department of Transportation is currently reviewing Tesla's (NASDAQ: TSLA) application to operate autonomous vehicles both with and without a driver, with a decision now expected by the end of August.

Key Points in This Article: The S&P 500's historical 10% annual returns have made Vanguard S&P 500 ETF (VOO) and State Street's SPDR S&P 500 ETF Trust (SPY) go-to choices for passive investors.

Investors have checked plenty of boxes off their 2021 market bingo cards lately: a V-shaped recovery in the S&P 500 after a quick bear market, a wild cryptocurrency rally, and beaten-down meme stocks generating short squeezes.

Amid growing concerns about economic stability and the implementation of President Donald Trump's trade tariffs, investors have been anxious this earnings season. Case in point is semiconductor giant Advanced Micro Devices Inc. AMD, which recently disclosed a mixed performance for its financial disclosure.